cGxP.wire https://validator.w3.org/feed/docs/rss2.html Exero Medical Highlights FDA Breakthrough xBar Study at ASCRS 2026 Neurogene Highlights Rett Gene Therapy Progress at ASGCT Encoded Therapeutics Expands CNS Gene Therapy Pipeline Eli Lilly Strengthens GLP-1 Leadership With New Foundayo Trial Results Medicenna Advances MDNA11 Melanoma Trial in Italy AskBio Expands Rare Disease Pipeline With AB-1009 Pompe Trial Milestone AIRNA Showcases RNA Editing Advances at ASGCT 2026 Enlitic Expands AI Radiology Platform Into New Zealand Definium Therapeutics Begins Phase 3 DT120-ODT Study Boehringer Expands Immunology Pipeline With Immunitas Deal Tolion Health AI Expands Digital Brain Health With New AI Coach Castle Biosciences Wins 2026 Genomics Innovation Award BMS and Hengrui Form $15 Billion Drug Development Alliance Alkermes Reports Strong Phase 3 LUMRYZ Trial Data Rigel Expands Oncology Portfolio With VEPPANU Licensing Deal Mirai Bio Advances In Vivo CAR-T Platform at ASGCT Servier’s Emi-Le Earns FDA Breakthrough Status Novo Nordisk Expands Wegovy Leadership at ECO 2026 Hill’s and Bond Gain FDA Clearance for Pet Protein Merck Unveils Major Oncology Advances at ASCO 2026 Henlius Wins U.S. FDA IND Clearance for HLX05-N Roche Gains CE Mark Approval for Elecsys pTau217 Test Novo Nordisk Reports 28% Weight Loss With Higher-Dose Wegovy Caris Life Sciences Shows WES Improves Immunotherapy Survival Prediction Bristol Myers Squibb Secures EU Approval for Sotyktu in Psoriatic Arthritis PulseSight Reports Positive Phase 1 Results for PST-611 FDA Expands Drug Repurposing Initiative for Rare Diseases aTyr Pharma Advances Efzofitimod Phase 3 Sarcoidosis Program Apnimed Highlights Phase 3 AD109 OSA Data at ATS 2026 Johnson & Johnson Showcases Neuropsychiatry Data at APA 2026 Dark Horse Consulting and KunTuo Partner to Accelerate CGT Trials Myrtelle Presents MYR-101 Canavan Disease Data at ASGCT 2026 Partner Therapeutics Strengthens Oncology Portfolio With BIZENGRI Corvention Wins FDA Clearance for KardiaPSI Balloon Vasa Therapeutics Highlights VS-214 at AHA 2026 GSK Partners With SBP Group to Expand Hepatitis B Treatment Innovent Secures Third NMPA Breakthrough Status for IBI363 Transpire Bio Gains FDA Acceptance for High-Strength Generic Trelegy Nanoscope Therapeutics Highlights MCO-010 Vision Data at ASGCT 2026 Kingdom Reports Positive Dog Gut Health Study Results Alpha Tau Completes Enrollment in Pivotal ReSTART cSCC Study Actio Biosciences Initiates KYRON Phase 1b/2 Trial for KCNT1-Related Epilepsy Azalea Therapeutics Unveils First-Ever In Vivo TRAC-CAR T Cell Engineering Breakthrough at ASGCT 2026 FDA Releases Pregnancy Safety Guidance for Drugs and Biologics Caris Life Sciences Files NY Approval for Caris Assure Persistent Strengthens Life Sciences AI Through Databricks Longeveron Reports Constructive FDA Meeting Ahead of ELPIS II HLHS Data Readout Halozyme and GSK Partner on Next-Gen ADC Cancer Therapies Mabwell Wins FDA IND Clearance for 9MW5211 in IBD Argenx Gains FDA Approval Expanding VYVGART to All gMG Patients